Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2022 Mar 24;2(3):e0000075. doi: 10.1371/journal.pgph.0000075

Co-production of knowledge as part of a OneHealth approach to better control zoonotic diseases

Festus A Asaaga 1,*, Juliette C Young 2,*, Prashanth N Srinivas 3, Tanya Seshadri 4,5, Meera A Oommen 4, Mujeeb Rahman 4, Shivani K Kiran 6, Gudadappa S Kasabi 6, Darshan Narayanaswamy 6,7, Stefanie M Schäfer 1, Sarah J Burthe 8, Tom August 1, Mark Logie 1, Mudassar M Chanda 9, Subhash L Hoti 10, Abi T Vanak 4,11,12, Bethan V Purse 1
Editor: Giridhara Rathnaiah Babu13
PMCID: PMC10021618  PMID: 36962247

Abstract

There is increased global and national attention on the need for effective strategies to control zoonotic diseases. Quick, effective action is, however, hampered by poor evidence-bases and limited coordination between stakeholders from relevant sectors such as public and animal health, wildlife and forestry sectors at different scales, who may not usually work together. The OneHealth approach recognises the value of cross-sectoral evaluation of human, animal and environmental health questions in an integrated, holistic and transdisciplinary manner to reduce disease impacts and/or mitigate risks. Co-production of knowledge is also widely advocated to improve the quality and acceptability of decision-making across sectors and may be particularly important when it comes to zoonoses. This paper brings together OneHealth and knowledge co-production and reflects on lessons learned for future OneHealth co-production processes by describing a process implemented to understand spill-over and identify disease control and mitigation strategies for a zoonotic disease in Southern India (Kyasanur Forest Disease). The co-production process aimed to develop a joint decision-support tool with stakeholders, and we complemented our approach with a simple retrospective theory of change on researcher expectations of the system-level outcomes of the co-production process. Our results highlight that while co-production in OneHealth is a difficult and resource intensive process, requiring regular iterative adjustments and flexibility, the beneficial outcomes justify its adoption. A key future aim should be to improve and evaluate the degree of inter-sectoral collaboration required to achieve the aims of OneHealth. We conclude by providing guidelines based on our experience to help funders and decision-makers support future co-production processes.

1. Introduction

Zoonotic diseases that originate from animals make up 60% of emerging infectious disease events worldwide [1] and disproportionately affect poor tropical communities [24], accounting for an estimated 26% of Disability Adjusted Life-Years lost to infectious diseases in low- and middle-income countries (LMICs). Globally, a majority of poor communities depend on healthy ecosystems for livelihoods, welfare and food security particularly in LMICs. Upsurges in incidence of several high burden zoonoses have been linked to ecosystems being degraded or destroyed (e.g. malaria [5], Leishmaniasis [6,7], Crimean-Congo Haemorrhagic Fever Virus) while differential exposure rates among communities and individuals have been linked to specific human activities and resource-use within ecosystems [811].

Despite increased global and national attention on the need for effective strategies for zoonoses control, rapid action is often deterred by poor evidence-bases and limited coordination between stakeholders who do not normally act in concert (e.g. animal health, public health, forest departments), particularly in LMICs including India [12,13]. Such responses are also expected to be led by public health departments, which are typically organised vertically (i.e. responding to priorities and programs conceived higher up in their own sector rather than exchanging with other sectors). Health departments in many countries (especially in the global South) struggle with under-financing and the need to organise interventions for non-communicable diseases, maternal and child health and non-zoonotic human infectious diseases. In addition, the limited leadership in such departments may impede the effective control of zoonoses, both in terms of technical leadership (e.g. evidence-based disease control measures) and managerial leadership regarding the organisation of human and financial resources [14].

The global OneHealth paradigm is an approach which recognises the “interconnectedness of human health, wildlife and domestic animal health and the environment” and the value of evaluating these interactions in an integrated, cross-sectoral and transdisciplinary manner to reduce pathogen transmission risk and mitigate disease impacts [1517]. Poor cross-sectoral integration has hampered effective policy-setting for zoonotic diseases and understanding of the mechanisms that underpin emergence, impacts and effectiveness of interventions [3,18,19]. Many of the current risk models and information systems for zoonoses are not tailored to the needs of decision-makers, at the most relevant scales, resulting in strategies to address zoonoses that are either inadequate, and/or not implemented by those who need them most [20].

Given such significant constraints, Leach & Scoones [20] recommend that disciplinary and sectoral perspectives should be “triangulated” with attention to framing assumptions, policy narratives, politics and values. Such a co-production approach is linked to a number of research strategies that aim to engage more and better with stakeholders, including Participatory Action Research [21], community-based participatory research [22] and Mode 2 knowledge production [23]. Knowledge production used in this context refers to the ways scientific knowledge is produced and applied. Alternatively referred to as transdisciplinarity as it affords the integration of knowledge from academic and non-academic stakeholders [24]. Two modes of knowledge production are commonly characterised—mode 1 and 2. Whereas in mode 1 problems are set and solved in a context governed largely by the interest of a specific community/discipline, mode 2 knowledge is carried out in a context of application through collaborative working by multidisciplinary teams [23,25]. Such methods actively engage stakeholders–seen as both knowledge holders and decision-makers–as agents of change in terms of the research process and its implementation [21,2629].

Integrating different types of stakeholders to inform decisions has a strong grounding in international policy-making, enshrined in Article 8(j) of the United Nations Convention on Biological Diversity, Agenda 21 of the Aarhus Conventions, the FAO/OIE/WHO collaboration (Tripartite) and associated regional or national approaches. The rationale for such integration arises from the hypothesis that such forms of integration encompass a broader diversity of knowledge, experience and expectations [30], leading to improved management [31,32]. In addition, collectively agreed decisions acknowledging diverse knowledge may be more socially and politically acceptable [3335]. Besides, the integration of diverse knowledge on improved equity, stewardship and efficiency has been identified as being a priority for OneHealth initiatives [36]. Here we argue that co-production is a particularly useful approach to use in the context of developing acceptable and implementable strategies to better address zoonoses. This is a context where multiple stakeholders across public health, forestry, animal health sectors and scales (from local to national) and local communities have knowledge of, and knowledge needs relating to zoonoses, but where this knowledge is not integrated or communicated between stakeholders, with negative impacts on humans and their well-being. Thus, implementing a participatory co-production process (embedded within a OneHealth systems thinking) offers a practical lens to iteratively and collaboratively engage cross-sectoral stakeholders at different stages of the framing, development and implementation of context-specific knowledge and tools to improve zoonoses management. In essence, participatory co-production process approaches help appreciate and understand different viewpoints, priorities and decision-making processes and achieve better disease prioritisation, research, communication and implementation of existing data and tools [4,17,20,37,38].

Various authors have outlined the challenges of co-production processes [3941]. Challenges include the paucity of examples of co-production around population-level policy and practice interventions, with co-production processes often focussing on single communities and not on policy change [4244]. Co-production across sectors for zoonotic/communicable diseases also revolve primarily around prioritisation of diseases and research agendas, rather than longer term cooperation to co-develop and operationalise particular interventions or research studies [45,46]. Whilst some studies have highlighted the advantages of integrating stakeholder knowledge on key risk factors into epidemiological models to inform interventions [38], no studies have explored the approach of cross-sectoral and multi-scalar co-production in the development of understanding of risk factors, predictive models for zoonoses and control interventions. The potential outcomes and learning from such an approach could be far reaching for developing models and interventions for zoonoses in other settings.

In this paper, we outline a co-production initiative in southern India that implemented a novel interdisciplinary approach to create a decision support tool (DST) for control of Kyasanur Forest Disease (KFD) with stakeholders at local to national scales, across the public health, animal health and forest policy sectors. First, we introduce our study system and context and outline our co-production process, including the theory of change framework. We go on to describe the process of co-production, including the benefits and challenges encountered and how these were addressed through an iterative approach. We finish with a summary of lessons learned and recommendations for decision-makers and researchers for future co-production of zoonotic disease tools and management.

2. Methods and approaches

2.1 KFD study system

Kyasanur Forest Disease (KFD) is a tick-borne haemorrhagic viral disease that affects poor communities in the forests of the Western Ghats mountain range in Southern India (across the states of Karnataka, Maharashtra and Kerala), and can be fatal in up to 10% of unvaccinated infected people [4750]. Communities at particular risk of exposure to KFD include, forest dwellers, traditional societies and settled village communities that harvest non-timber forest products and access food, fuel and fodder, plantation and forest department workers, farmers who graze livestock or cultivate on forest fringes [47,48,5153]. Aside from KFD affecting diverse forest users, it has a broad vector and host range, with a complex transmission cycle in which various tick species (notably the Haemaphysalis genus, but also Ixodes) and vertebrate hosts have been implicated, including wild rodents and shrews, monkeys and some birds [53]. Humans contract KFD when bitten by an infected tick but are incidental hosts for the disease and are not involved in onward transmission [54,55]. Therefore like the Lyme disease agent, Borrelia burgdorferi, KFD virus is a "spill-over pathogen" for which almost every human case represents a spill-over event from a wildlife reservoir via the infected tick vector [55].

The work reported here is a result of the MonkeyFeverRisk project, which aimed to develop an inter-disciplinary DST to help communities minimise exposure to zoonotic diseases whilst maximising the livelihood benefits derived from tropical forests. The project used a OneHealth approach and was interdisciplinary, linking expertise in public and animal health, forest and wildlife ecology, human behaviour and priorities, empirical measurements and models to understand the ecological and social processes that make communities more vulnerable to KFD.

2.1.1 Actors involved in disease management in India

The organisational landscape for disease management in India is multi-layered involving different actors operating at different levels across national, state, district, Taluka (sub-district) and village/local government scales (Fig 1). Districts are the typical administrative sub-divisions in which disease management is organised, with sectorally-defined department heads who monitor and oversee operations within their sectors/departments. However, Indian districts are relatively large, covering populations of 1–3 million. Although organisation of animal and human health services is the mandate of sub-national state governments, disease surveillance is a function retained at the national government level under India’s Constitution [13,56,57]. Among ‘OneHealth’ actors involved in disease management, four focal institutions have overarching responsibility for zoonoses prevention and control: the National Centre for Disease Control (NCDC), Indian Centre for Medical Research (ICMR) and the Indian Council for Agricultural Research (ICAR) and the national disease control programs implemented by the Ministry of Health and Family Welfare (for e.g. the National Vector-borne Diseases Control Program). The NCDC and ICMR are human health institutions under the Ministry of Health and Family Welfare (MoH&FW) focussing on human wellbeing. ICAR and the Department of Animal Husbandry and Dairying (AH&D) respectively fall under the Ministries of Agriculture and Farmers Welfare (MoA&FW) and Fisheries, Animal Husbandry & Dairying, promoting animal health for food production and safety. The NCDC provides technical guidance and support to state governments in the event of health emergencies and manages the respective national disease surveillance programme and the National Standing Committee of Zoonoses (NSCZ). The ICMR, an autonomous department within the MoH&FW (comprising 26 centres of excellence–e.g. National Institute of Virology, National Institute of Malaria Research), administers disease research through grants to respective medical colleges, universities and affiliated laboratories (see Fig 1). Conversely, ICAR regulates a large network of specialised research and teaching institutions focussed on agriculture and veterinary sciences. The Wildlife sector, which is the third ‘OneHealth’ sector [58], under the auspices of the Ministry of Environment, Forest and Climate Change (MoEF&C) responsible for wildlife health on conservation-related concerns [13,56]. The functionally disparate actors in disease management further highlights the importance of a co-production approach to better understanding and managing zoonotic diseases in India.

Fig 1. A simplified illustration of the sectors and the politico-administrative actors of the KFD management in India including actors from each sector that are impinging on the system or are impacted by KFD in each sector.

Fig 1

2.2 Co-production process

Co-production is particularly well suited to the development of models to understand and predict zoonotic diseases, where stakeholders from different sectors and scales are integral as knowledge holders and future model users. The steps of co-production in the context of the project were:

  • Engaging with key stakeholders to frame the research

  • Feeding in knowledge from wider stakeholders into research and resulting tools

  • Validating the DST

2.2.1 Selection of workshop participants

Prior to organising the workshops, the research team conducted a stakeholder mapping exercise, which culminated in a list of current and potential cross-sectoral actors involved in KFD management at local, national or state level. Based on this stakeholder list, workshop participants were purposively selected to warrant (a balanced) representation of policy/decision-makers from the human health, animal health and forestry sectors with designated roles in KFD management, who had the potential to provide relevant, detailed and diverse information about the KFD system. The variety of sectoral representation, participants’ experience with KFD prevention and control, and the ability to assess the value of the DST and other project outputs were the main criteria for inclusion of participants.

In recruiting prospective participants for the workshops, formal introductory letters were sent to the appropriate state departmental directorates (in accordance with institutional protocols), explaining the objectives of the overall project, and requesting them to depute up to 7 staff from their respective departments to attend the workshops. The introduction letters were sent to the Karnataka state directorate of health and the NCDC (public health sector), Department of Animal Husbandry and Veterinary Services (DAHD) (animal health sector) and State Forest Department (environment sector) respectively. Two of the co-authors (MMC and SLH) followed up with telephone calls to further explain the purpose of the workshops and confirm participation at the sessions, in accordance with administrative protocol and local custom. The characteristics of the workshop participants are outlined in S1 Table (see supplementary material).

2.2.2 Multi-stakeholder workshops

As part of the co-production process, a participatory consensus-building technique–nominal group technique (NGT)–was employed in the two multi-stakeholder workshops. The NGT is a stepwise, democratic and participatory process used to generate a list of collectively established priorities [59,60]. In this context, the first ‘framing’ workshop was convened in Bengaluru in August 2018, with 19 experts from different KFD-affected districts state level officials of Karnataka, Maharashtra and Kerala from the public health (6 participants) and animal health (10 participants), agriculture (one participant), forestry (one participant) and social welfare (one participant) sectors. Given the endemicity of KFD in a number of districts in Karnataka state, Bengaluru was deemed a convenient location for the workshops. The workshop aimed to map stakeholders’ knowledge about KFD, prioritizing risk factors for the disease, identifying key policies that affect KFD, and feeding that knowledge into project approaches and models. To this end, the facilitated discussion and simple voting process (rank-ordering of risk factors) of the NGT helped circumvent typical power dynamics of the diverse stakeholder groups and afforded equitable contribution to group discussions [59]. Moreover, using the NGT during the workshop (1) afforded quick collation of considerable amount of information about stakeholders’ priorities and perspectives within a short time frame using minimal resources in a single event, and (2) alleviated possible researchers’ biases as data was interpreted by participants [59,60].

In between the framing workshop and the knowledge and experimentation workshop, the desk-based spatial DST was developed using a multi-pronged approach. Firstly, human case data were collated across the KFD-affected areas and modelled in relation to risk factors identified by stakeholders or in the scientific literature to produce and validate risk maps for disease spill-over (as described in detail in [61]. A desk-based decision support tool (based on the Shiny app interactive web technology from RStudio (https://shiny.rstudio.com/) was then constructed, integrating disease surveillance and landscape data, alongside the risk maps, accounting for the stakeholder preferences identified in the framing workshop for how seasonal and geographical information should be presented and overlaid to inform disease management. Importantly, a post-doctoral researcher from the research team was embedded in the health department throughout this process and, alongside data collation and modelling was involved in the KFD response, participating in interventions such as inter-departmental sensitisation workshops for decision-makers across sectors, and community awareness raising activities. This allowed for further reciprocal knowledge integration and feedback on utility and contextualisation of the developing project DST and risk guidance in between the project workshops.

The second workshop, focussing on knowledge integration and experimentation, was held in Bengaluru in December 2019. At this second workshop, we presented a prototype desk-based spatial DST to stakeholders (developed based on their input in the first workshop), encompassing predictive risk maps for human spill-over, maps of landscape risk factors and features that guide interventions, human cases and tick and monkey infections from surveillance, and awareness raising material on key risk factors and affected communities. As part of the experimentation process of the workshop, stakeholders were invited to test the DST. During this process, the stakeholders identified many functional characteristics to be enhanced or added to the DST. The project team divided these into categories (site- or area-based information, individual level information, temporal or alert-based information, awareness raising and capacity building information, and other) and identified time lines and feasibility of integration. We also scoped out whether development of a mobile App would benefit management and, if so, what functionality should be included and for which groups of end-users. The second workshop was attended by 34 practitioners and experts from different KFD-affected districts and state level officials of Karnataka, Maharashtra and Kerala from the public health (22 participants), animal health (6 participants) and other sectors (6 from agriculture, forestry and social welfare sectors). Despite efforts to achieve a balanced sectoral representation at both workshops, this was not achieved due to circumstances beyond the control of the project team. A case in point is the major flooding event which occurred in parts of Kerala and Karnataka states (coinciding with the first workshop), which resulted in the withdrawal of some invitees who had hitherto confirmed their participation. Besides, the first workshop clashed with a field programme of the forest department, which meant that some initially deputed officials had to decline the invitation to attend the workshop. The second workshop had a disproportionate representation of Public Health actors principally due to the specific expression of interest to participate received from the health departments officials stationed at Sagara (an area newly affected by KFD that season). The project team granted this request as it was deemed a good window of opportunity to obtain feedback on the prototype desk-based spatial DST as well as build good rapport for on-ward dissemination and uptake of project outputs. Nonetheless, further follow-up interviews and conversations with under-represented stakeholders (principally from the forestry department) during the course of the project (including the national KFD stakeholder consultation workshop) afforded in-depth understanding of their perspectives and inputs into the DST development.

In both workshops, the approach adopted was inclusive, building on small group discussions and developing joint worksheets. In both workshops, we allocated participants to sub-groups to ensure that each sub-group had representation of practitioners and experts from different districts and ideally from different sectors. A facilitator on each table moderated the discussion in line with the objectives. The facilitator was instructed to initiate the discussion with clear explanation of the session and discussion topics; to provide general instructions such as duration, ground rules and expectations of the discussion; and to note the important points for each topic on a worksheet. A rapporteur was allocated to each table, taking detailed notes from the discussions and supporting the facilitator. At the end of each discussion session, each rapporteur and facilitator communicated the main points to a colleague responsible for synthesizing the key points, who entered the information into the Mentimeter software to allow for prioritization of issues with workshop participants. The facilitators adopted an opened-ended and friendly approach, which ensured that the sessions were highly participatory, as participants were encouraged to feed in their knowledge and experience during the workshop using a range of different approaches including group discussions, brainstorming and prioritization exercises. Fig 2 presents a graphical representation of the retrospective theory of change on researcher expectations on the system-level outcomes of the co-production process adopted in the context of our project. It highlights the various key elements and processes underpinning the co-production process and how they relate to the envisioned outcomes and impacts.

Fig 2. Graphical representation of the retrospective theory of change on researcher expectations and the system-level outcomes of the co-production process adopted in the MonkeyFeverRisk project.

Fig 2

The key components of the theory of change framework were as follows: (i) planned activities which included joint problem-framing with cross-sectoral actors to better understand the contextual risk factors and knowledge gaps, (ii) intermediate outputs comprising the social and ecological fieldwork, design and experimentation of a decision-support tool, and (iii) anticipated outcomes which ultimately contributes to fostering inter-sectoral collaboration and increased disease preparedness.

2.3 Data analysis

The collated qualitative data from the workshops (including audio transcriptions, observation notes and suggestions made by participants) were thematically analysed within a deductive framework. After transcribing the audio recordings of the workshop discussions, the transcripts were manually coded (line by line and axial) independently by three of the co-authors (JCY, MAO and FAA), following Braun & Clark’s [62] thematic content analysis approach. Exemplar quotations from participants and observations of the facilitation team were also collated. Each reviewer (JCY, MAO and FAA) generated themes and sub-themes, which were subsequently compared and refined to produce the final thematic analysis. If there were any disagreements, reviewers discussed themes to collectively agree on revisions. All participant information were de-identified using pseudonyms for the analysis and report-writing; these pseudonyms are reported here.

2.4 Ethical approval and consent to participate

The study protocols were approved by the Institutional Ethics Committee of the Institute of Public Health (IPH IEC) (Study ID, IEC-FR/04/2017), Ashoka Trust for Research in Ecology and the Environment (IRB/CBC/0003/ATV/07/2018) in India, and received a Favourable Ethical Opinion from the Liverpool School of Tropical Medicine Research Ethics Committee in the United Kingdom (research protocol 17/062) under the MonkeyFeverRisk project. All study participants were adults and gave full prior-informed verbal and written consent before the conduct of the workshops. The collated data from the workshops were duly anonymised using de-identifiers or pseudonyms prior to analysis.

3. Results

3.1 Insights, benefits and challenges from each stage of the co-production process

3.1.1 Problem framing

As part of the framing workshop, stakeholders were asked about what they perceived as key risk factors (see Fig 2). Facilitators compiled and typed up sticky notes (Part 1) for participants to rank individually. Participants were given 5 stars to use as they wished in ranking the identified risks. Based on the ranking exercise, the key risk factors that stakeholders felt needed to be addressed for effective KFD management are highlighted in Table 1. Whilst a number of these risk factors were addressed in the project (see last column of Table 1), it is worth noting that not all of the risk factors identified by stakeholders could be encompassed in models or in fieldwork (for a detailed description of the modelling approach employed, see Purse et al., 2020). For example, in spatial risk models it was not possible to integrate factors like variation in health data management or reporting of monkey deaths by the Forest Department (some species of primates are considered amplifying hosts for KFD), low vaccine uptake or awareness of KFD as model inputs [61], though these factors could be considered in model interpretation and factored into household surveys and information material. A more complete list of ranked risk factors and what changed and/or strengthened over the course of the project is presented in S2 Table.

Table 1. Risk factors identified and ranked by participants of the framing workshop, and how these were integrated in the MonkeyFeverRisk project.
Ranking Risk factors Number of votes How risks were addressed in project
1 Lack of education/awareness 10 Tick information cards were produced to inform local communities about risks from ticks and tick protection measures. Development of an educational video in progress.
2 Under or late reporting of monkey deaths 9 Accounted for in data interpretation in risk modelling
2 Deforestation and/or forest degradation 9 Integrated as a risk factor in models
2 Lack of awareness of preventative measures (tick repellants, vaccination) 9 Measured in cross-sectional household surveys WP2 Tick information cards produced (see above).
3 Lack of awareness or understanding of alternative hosts 8 Addressed in household and ecological surveys
4 Human use of forests 7 Addressed in household surveys and in spatial risk modelling
4 Low vaccination coverage 7 Addressed in household surveys and in spatial risk modelling
4 Poor diagnostics and surveillance 7 Improving surveillance and diagnostics is not a direct project aim but could result from a strengthened OneHealth network. Ecological analysis of vector and alternate hosts will inform surveillance strategies.
4 Lack of OneHealth policy 7 Project established a OneHealth WhatsApp network on KFD which facilitates networking amongst people involved in KKFD management. Project members attended National and State level technical committees on KFD and discussed OneHealth approach
5 Poor data management 6 The project provided a blueprint for future data management on KFD, for example ensuring that cases were georeferenced at a household level to capture landscape conditions favouring spill-over
5 Poor understanding of tick ecology 6 Addressed in ecological surveys
6 Side effects and concerns about vaccines 5 Measured as part of the household surveys but not a direct research project aim
7 Living in or around forests 4 Addressed in risk modelling, household surveys and ecological surveys (stratified by forest proximity)
7 Favorable environment for ticks 4 Addressed in ecological surveys (habitat associations were measured)
7 Poor tick identification 4 Addressed in ecological research and capacity building (see Table 2)

The participants of the workshop also shared what their key needs pertaining to KFD management were from the project (Table 2).

Table 2. Key needs identified by participants of the framing workshop–and how these needs were addressed in the project.
Key needs identified by workshop participants How needs were addressed in project
Human resources: need for better trained manpower; more equipment; tick experts and taxonomists Institutional capacity for morphological and molecular tick identification was built in partner institutes and within the health system (training of district entomologists). Tick taxonomy resources were developed that will be made publicly available
Improved surveillance: need for active surveillance; surveillance for disease, vectors and hosts WP3b provided risk maps and models that were integrated into a desk-based App “KFDExplorer” to improve targeting of surveillance. WP3a advanced understanding of the ecological communities most strongly linked to KFD and developed protocols for tick and small mammal surveillance.
Better diagnostic facilities Not a direct research project aim but OneHealth network can advise on location/type of facilities
Better communication: real-time reporting; social media use Part of experimentation phase
Funding for research and action Not a direct research project aim but opportunities were communicated through the OneHealth network
Better understanding of disease ecology: alternative hosts and vectors; seasonality; tick movement; tick distribution; tick ID and taxonomy Ecological surveys and research advanced this understanding, and produced Tick Information cards (see above). Published review of the ecological evidence base for current KFD management for disease managers [55].
Vaccines and vaccination innovations: better quality/efficacy/single dose; availability; shelf life Not a direct research project aim
Multi-sectoral coordination: better communication and coordination Stakeholder workshops; WhatsApp groups, establishing a OneHealth network
Raise profile of KFD and hence generate political will for KFD control and management Project members engaged with a wide range of media outlets to raise awareness of KFD and attended National and State level government technical committees on KFD to provide advice and describe the OneHealth approach
Improved knowledge, awareness and better practices for KFD management Tick Information cards produced and video in progress–see above). Review of the ecological evidence base for current KFD management (see above).
Improve detection of at-risk human populations early Ecological surveys and spatial risk models improve understanding of the landscape conditions favouring spill-over, whilst the household survey indicated livelihood risk factors and activities for KFD
Restrict human-forest interface wherever feasible Covered in household surveys as part of raising awareness. Analysis of ecological data to identify important non-forest interfaces (other than forest) affecting human spill-over dynamics.
Remove invasive species Ecological surveys measured links between invasive plants, tick abundance and KFD

An important input from the framing workshop was the understanding from workshop participants of the wide range of interacting policies and actors that impact or are impacted by the disease system including longer term political and economic processes that might affect disease transmission. Concerning the impacts of national and state level policies on KFD management, key policies that were identified as having a negative impact or as being poorly implemented were those concerning deforestation, grazing and encroachment in and around forest areas, with abrupt shifts in land use in these areas being identified as making communities more vulnerable to KFD. In the health sector, policy changes that were suggested to benefit management were making KFD a notifiable disease (discussed further at the 2019 National Technical Committee on KFD), learning from wide-scale vaccination and vector control campaigns for other diseases, improving the coordination between animal health professionals conducting monkey post-mortems and public health professionals involved in treating human patients, improving the screening of livestock for pathogens and ecto-parasites before transportation.

Concerning the mapping and forecasting information needed to manage KFD, workshop participants were of the opinion that making available risk predictions at scales from village-level to clusters of villages would be most helpful to plan vaccination and awareness campaigns. Participants requested that data on environmental risk factors such as climate, land use change, altitude and livestock densities should appear alongside risk maps in a tool, together with contextual features like roads and household locations that health managers routinely use to plan their management across the landscape [61]. Interfacing the seasonal activity of ticks with seasonal activities conducted by different groups of forest users in the tool was felt to be very important. Predictions of the month and villages at highest risk would be most useful at least six but better two months before the KFD season. The project team tailored the scale and appearance of the tools to these needs.

To summarise, the first workshop was instrumental in collaboratively framing the research priorities of the project and its future direction. As a direct result, the project approaches and models [61] were changed to reflect:

  • New hypotheses, for example ‘what makes communities more susceptible and exposed to KFD’ that could then be tested with models/fieldwork within and beyond the project

  • Improved integration of key risk factors into understanding and tools for zoonotic diseases

  • Maintained focus on quantifying both ecological and social components of risk at regional and landscape scales

  • Tuning the study grain and models to the scale of landscape use by people, hosts and vectors

  • Developing predictive tools that account for the way that disease managers collect disease data, interpret and use seasonal and geographical information.

3.1.2 Knowledge integration and experimentation

Following the joint framing of the research, the next step in knowledge co-production focussed on knowledge integration and experimentation, in the second workshop (Fig 2).

As part of the knowledge integration process, a wide range of users and uses were identified by stakeholders (See Table 3). This identification was far wider ranging than we had initially planned in the project team, meaning more effort was needed to manage expectations about which users and uses could be encompassed in the project time frame, but this allowed for a tailoring of specific functionality to end-user needs. For example, stakeholders felt that the desk-based App would be suitable for officials involved in KFD management at block level up to National and State Levels. For users on the ground such as health workers and Primary Health Centre Medical officers, a Mobile Phone App was felt to be more suitable. Across the three main departments involved in KFD management, namely the Public Health, Animal Health and Forest Departments, different groups or levels of users that (a) might benefit from the DST (b) and/or might enter data into the DST were identified. For each user, Table 3 presents the potential ways they would use the tool given their role in KFD management, and indicates whether and what type of data they might enter.

Table 3. Key potential users and uses of the DST across the three main departments involved in KFD management, namely Public Health, Animal Health and Forest, as identified by stakeholders at the second workshop.
Level Details Animal Health Department Public Health Department Forest Department
National Level User National Centre for Disease Control
Use of DST Guide supervision of Outbreak investigations, research planning, Technical meetings and reporting to higher National level officials
State Level User Joint Director Animal Health Joint Director Communicable Diseases Principal Chief Conservator of Forests
Use of DST Tool used to view risk and report to higher officials and ministers, assist with planning and implementation of field activity, resource and media management, to facilitate inter / intra departmental coordination Risk maps to guide tick control, locations of IEC hoardings, monkey death surveillance, staff protection
Data entry Resource inventory at State level, checking data entered at lower levels
District Level User Deputy Director Animal Health District Health Officer Divisional Forest Officer
Use of DST Human case and monkey death locations and risk maps would facilitate supervision/planning of field implementation and tick vector control measures Use tool to supervise field implementation, resource planning, manage media and mobilize local elected representatives As above
Data entry District inventory of resources for PPE and tick control measures District inventory of resources such as vaccines and repellents, check data from lower levels Check data from lower levels
Taluk Level User Assistant Director Animal Health Taluka Health Officer Assistant Conservator of Forests
Use of DST Human case and monkey death locations and risk maps would facilitate supervision/planning of field implementation and tick vector control measures Use tool to supervise field implementation, resource planning, manage media and mobilize local elected representatives As above
Data entry Taluka inventory of resources for PPE and tick control measures Taluka resource inventory and vaccine coverage, case locations, referrals, information on samples Check data from lower levels
Ground level or Periphery User Veterinary Officers (Veterinary Dispensary) Primary Health Centre Medical Officers (PHC MOs) Range Forest Officer
Use of DST Human case and monkey death locations and post-mortem protocols in tool would facilitate role in tick vector control (on livestock), monkey post-mortems and sample collection PHC MOs would use risk maps and IEC (e.g. on KFD symptoms, risks from ticks, tick prevention measures), stock inventory at Taluka level to plan and supervise field implementation As above
Data entry post-mortem results and some monkey death locations (where not entered by the forest department PHC resource inventory, vaccine coverage of population, case locations and patient histories, information on suspected samples for the laboratory and referrals Monkey death events, human case locations, vaccination status of staff, hoarding locations
User Junior Health Workers Forest Guard
Use of DST Would use risk maps and IEC (e.g. on KFD symptoms, risks from ticks, tick prevention measures), stock levels of oil and vaccines, to target preventative measures in community Raise awareness of risk areas and monkey deaths among public
Data entry Fever surveillance, monkey deaths, human cases Report monkey death events, human case locations
User Accredited Social Health Activists (ASHAs)
Use of DST Would use risk maps and IEC (e.g. on KFD symptoms, risks from ticks, tick prevention measures), stock levels of oil and vaccines, to target preventative measures in community
Data entry Fever surveillance, monkey deaths, human cases

IEC = Information-Education-Communication.

Key uses identified for mapped information in the DST at the ground-level were to enable targeting of field management activities such as community engagement on preventative measures, tick control and monkey death reporting. Awareness raising information on KFD symptoms, risks from ticks, tick prevention measures, monkey post-mortem protocols was also felt to be very beneficial at the ground-level. Ground-level users (i.e. field health workers linked to primary health centres) were likely to be able to enter important geographical and individual-level data (such as human case locations and case histories/outcomes, vaccine coverage, monkey death events and locations of tick and monkey samples testing positive for KFD virus (KFDV), forest guard and tourist routes) into the tool for use in management by the levels above. The risk maps that predict where human cases of KFD are likely to occur (based on whether locations have similar landscape conditions to locations that had KFD in the past) was one of the most popular functional aspect of the DST amongst stakeholders (Fig 3). It was suggested that preparedness for KFD could be enhanced if updated risk and outbreak maps could be provided each year, in time to guide pre-season tick surveillance, vaccination campaigns, as well as raising awareness amongst Primary Health Centres of KFD risk and diagnostic methodologies. Stakeholders suggested that inventories of public and animal health resources could be compiled within the DST to facilitate resource planning from Taluka level upwards, though this functionality is not yet incorporated and is planned to some degree under the Integrated Health Information Platform for India.

Fig 3. Snapshot of the KFDExplorer Tool showing south India overlaid with the human cases reported in 2019 to the Department of Health and Family Welfare Services, Karnataka.

Fig 3

The areas predicted to be highly suitable for spill-over of KFD to humans are highlighted in red versus areas predicted to be unsuitable for spill-over in blue. The right hand menus in green indicate how data on environmental risk factors, on KFDV-positive dead monkeys and KFDV-positive ticks, can be visualised alongside human case locations, whilst the use of a detailed base map depicts landscape contextual features that guide management such as villages and roads. Source data: Map base layer is from the OpenStreetMap (https://wiki.openstreetmap.org/wiki/Standard_tile_layer). This dataset is available under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication license (https://creativecommons.org/publicdomain/zero/1.0/) and any copy of or work based on this dataset requires the following attribution: This dataset is based on the dataset produced by the OpenStreetMap Foundation (https://osmfoundation.org/). The administrative boundary dataset used in this figure is from HindudstanTimesLabs (https://github.com/HindustanTimesLabs/shapefiles/), reproduced under the MIT License. Human case data are from the Department of Health and Family Welfare Services, Government of Karnataka.

Other potential beneficiaries of the DST identified by stakeholders (and which the project team had not considered previously) included the Agriculture and Horticulture Departments, Revenue Department, the Education Department and the Tourism Department. This cohort of latent stakeholders were envisioned as having an important “stake” in contributing to holistic efforts to KFD prevention and control [63]. For example, it was suggested that the Tourism Department might use the risk maps to better prepare in the tourist areas at risk from KFD.

In terms of communication and inter-sectoral coordination, stakeholders felt that the DST may facilitate networking and linkage of data between departments and districts–a key aim of the OneHealth approach. Stakeholders further suggested that information from the DST could help with media engagement and mobilization of local elected representatives at Taluka and district levels and could feed into multi-level inter-sectoral meetings at village, Taluka, district, state and inter-state levels.

The workshop resulted in a project team decision to seek translation funding to build the Mobile Phone App and continue to scope out functionality and data flows with key beneficiaries in Karnataka, working through the Virus Diagnostic Laboratory, Shimoga and connecting with teams developing other information systems. The process of Mobile App development would be informed by piloting of the desk-based DST (“KFDExplorer tool”) over the next 1–2 transmission seasons.

Another key outcome of the second workshop was the need to develop complementarity with existing tools. The World Health Organisation (WHO) Regional Office and the Indian Government have together developed and rolled out the Integrated Health Information Platform (IHIP) across India. Stakeholders felt that it was important that the DST be eventually integrated into IHIP to avoid peripheral workers from having to learn and enter data into multiple platforms. However, they also appreciated that the project DST was tailored for Kyasanur Forest Disease and, unlike IHIP at present, could be used to integrate and view information across sectors and included risk mapping and visualization of risk factors for KFD. Table 4 summarises some of the key distinctions between the MonkeyFeverRisk DST and the Integrated Health Information System that may affect and inform the integration process. Based on discussions with the regional office of the WHO after the workshop, a decision was made to continue developing the MonkeyFeverRisk DST (and viewed across sectors) as a stand-alone tool, but that efforts would be initiated to integrate key data from the tool such as the risk maps, risk factors and data gathered from other sectors into IHIP. Similarly, Public Health data gathered by IHIP may feed into future versions of the MonkeyFeverRisk DST. The strategy thus was to roll out MonkeyFeverRisk DST first independently of IHIP on Indian Government servers and then make arrangements with the WHO IHIP team for further integration, taking account of feedback from a broader range of end users during the KFD season. As at the time of submission of this paper, the first step has been delayed by the COVID-19 pandemic and the need for the e-hospital to manage COVID-19 data and provide tools to inform the response.

Table 4. Some key distinctions between the MonkeyFeverRisk DST and the Integrated Health Information System that may affect and inform the integration process.
MonkeyFeverRisk DST Integrated Health Information System
Spatial scale Household level for case locations, which enables fine-scale linkages between the environment and human cases to be made Health Centre and village level
Temporal scale Long term risk area predictions for preparedness Real-time event reporting and cluster identification
Data entry, access and visualization Ideally, all can see some geographical data at all scales though requires state level agreements across sectors and careful protection of individual data Set up so that users can only see the data for their own jurisdiction, not for neighboring areas or broader geographical areas (e.g. Primary Health Centre Medical Officers cannot see Taluk or block level data)
Data sharing across states can be arranged by agreement of state level department heads
Sectoral involvement Aiming for data entry and viewing across sectors though requires state level agreements across sectors and careful protection of individual data Public Health Sector only can view at present
Data sharing across sectors could be arranged by agreement of state level department heads
Risk factors Overlay of risk factors e.g. forest types, tick and monkey positives, human populations None
Risk maps Distance-based clustering in real-time during outbreak season

The second workshop continued the co-production process started in the framing workshop. The process focused on knowledge integration, through the presentation of the work carried out in the project so far, and the development of the DST, based on the needs and constraints of the stakeholders using the DST. As a result of the workshop:

  • The input from workshop participants on the decision-support tool fed into the further development of the tool.

  • The input from workshop participants on the App was shared and discussed with an App developer. This is resulting in an App that could be shared with workshop participants.

  • The project website was updated to provide more guidance documents such as maps, community guidance materials, resources for tick taxonomy and for members to share resources with each other.

  • IHIP integration was explored and results shared with workshop participants.

4. Discussion

Despite the widespread and growing interest in the role of co-production of knowledge in bridging the gap between scientific evidence and policy implementation as a pathway to strengthen health systems [64,65], there remains uncertainty on what co-production of research entails, and how and when to implement it to maximise impact of research outputs [59,64,66]. This is especially true in the context of OneHealth operationalisation in LMICs, where there is relative dearth of empirical evidence on how to actively and meaningfully engage diverse range of stakeholders at the various stages of the research process to co-produce and mobilise contextually and policy-relevant knowledge [13,66,67]. In this study, we presented our reflections of various activities that comprised a co-production process to actively engage a range of stakeholders at different stages of our research to co-produce knowledge and develop a spatial decision support tool (“KFDExplorer tool”) for improved KFD surveillance and control in India. As evidenced in our Theory of Change (see Fig 2), the workshops and engagement of key sectoral actors throughout the project duration framed the project’s design, and resulted in improved identification of risk factors and knowledge of socio-ecological processes affecting management of KFD as well as indirect input into the KFDExplorer tool and risk model development.

Whilst, as highlighted in the wider literature and also experienced in our presented study, co-production in OneHealth is a difficult and resource-intensive process requiring regular iterative adjustments and flexibility, the beneficial outcomes justify its adoption [59,67,68]. Implementing meaningful co-production in the context of OneHealth with the aim of improving zoonotic disease management necessitates a nuanced understanding of the underlying contextual factors that shape outcomes of collaborative engagements between researchers and decision-makers [13,69,70]. Our findings contributes to the burgeoning OneHealth literature, in which empirical studies are still sparse that describe successful and unsuccessful attempts to foster and sustain engagement with diverse stakeholders in co-producing OneHealth research to support zoonoses management, particularly in LMIC settings [56,64,67,71].

In our research project, the co-production process happened at the scale of the research team itself and led to impacts beyond our expectations. The development of the decision support tool benefitted from the pro-active steering by a member of the project team responsible for disease control in one state, and from having postdocs embedded in the Department of Health & Family Welfare Services (DHFWS), which led to improvements in the way surveillance data were collected and analysed. Good knowledge of the key stakeholder groups and embedding champions at the beginning part of the engagement process is pivotal for successfully creating co-produced research and translation into practice [59,72]. Moreover, trust building and continuous interactions between researchers and stakeholders, particularly in contexts where sectoral actors traditionally operate in “silos” remain fundamental [13]. Khayatzadeh-Mahani et al. [59] and Tembo et al. [72] argue that early engagement is a key principle for good co-production practice as it affords a window of opportunity to better understand stakeholders and ‘gate-keepers’ (values, interests, and context), develop trust and supports ethical and contextually-relevant research. Consistent with this argument, our flexible and early engagement with the DHFWS for instance, proved pivotal in establishing a good communication channel for receiving continuous semi-structured feedback (in addition to the more structured consensus-building NGT technique) and suggestions for tailoring project outputs for wider dissemination and uptake [59].

4.1 Creation of an interdisciplinary network

Consistent with the wider OneHealth literature [4,65,73], our findings suggest that fostering clear channels of communication among stakeholder groups at all stages of the co-production process is a critical first step towards improved collaborative arrangements. In this context, stakeholders themselves suggested the creation of an inter-disciplinary network (a dedicated and growing WhatsApp network sharing information relevant to KFD) which has facilitated information sharing and knowledge development in a quick and timely manner [55]. The workshops and collaborative working have also led to a broader culture of inter-sectorality, as demonstrated by the stakeholders in the second workshop highlighting wide-ranging sectors, scales and means required to leverage surveillance capacity across sectors (e.g. monkey deaths). For KFD, our workshops and co-production process, one of the first, enabled the formation of a large, interacting network of governmental and non-governmental stakeholders as well as representatives across sectors. In addition to a growing respect of each other’s contributions (which were hitherto restricted to specific silos) [13,74], this informal network, with its positive interpersonal interactions, is likely to serve as a core group in future endeavours related to disease management and control.

4.2 Institution of culture of inter-sectorality

It is a common-placed view that better appreciation of the complexity and diversity of interests, values and context of stakeholders is necessary to overcome barriers and leverage opportunities for meaningful engagement of cross-sectoral stakeholders [64,70,75]. In this vein, the broader culture of inter-sectorality achieved over the course of our project facilitated a better understanding of different sectors, including their constraints. One example of this was the need to integrate public health constraints into DSTs. Stakeholders’ discussion about resource inventories for KFD management revealed competing/conflicting needs of other diseases and/health conditions (e.g. key KFD personnel reassigned to support local COVID-19 response), highlighting that health systems do not respond to individual zoonotic diseases in isolation [76]. Communities vulnerable to KFD are also likely to be affected by non-communicable diseases and other zoonotic infectious diseases such as scrub typhus and Leptospirosis [77,78]. Health system responses to co-occurring diseases always trade off against each other but this will be even more pronounced in forest-dependent communities (most affected by KFD) that are often remote from healthcare infrastructure [79]. Joint landscape-scale modelling and empirical studies of diseases offer the potential to understand how and where diseases are co-circulating and why they bundle together in the landscape [76].

Another benefit from inter-sectoral work was the improved understanding of the ethics of delivering risk models to policy makers (after Boden & McKendrick [80]. The co-production process allowed us to ascertain what information managers were already using to guide targeting of interventions and to reflect on whether the risk models provided would constitute an improvement against this baseline and how these models should be used operationally, given uncertainties, to avoid mis-direction of resources. In addition, the co-production process highlighted the need for data protection and data sharing agreements across sectors and levels, issues of equity of data sharing and entry, and clarity of roles of different beneficiaries in disease and data management.

4.3 Transparency between researchers and cross-sectoral stakeholders

A major challenge in generating policy-relevant evidence and context-specific solutions concerns incentivising and sustaining stakeholder interest throughout the research process [67]. Within this purview, the implementation of the co-production process facilitated full transparency with stakeholders about the modelling process, inputs, outputs and quality by establishing early and clear lines of communication and mutual understanding around available data and key risk factors. Validation and beneficence of our models was further facilitated by knowledge integration, in particular gathering and analysing outbreak data in partnership with health departments, during ongoing outbreaks [61]. Co-production was vital for gathering outbreak data that reflected locations of exposure in the landscape; better understanding contextual socio-ecological risk factors; and tailoring the spatial resolution and outputs to the scale of forest use, and public health interventions. It was an advantage to have researchers from our project embedded in the health department for coordination of multi-sectoral participation in process, for cross-sectoral linkage of data and priorities and to enable us to identify a mechanism by which ownership of the KFDExplorer tool could be successfully transferred to and sustained within the health system. Such a collaboration was made possible by the early co-production process used in this project. Our findings thus support the emerging evidence that suggest that, iterative and transparent engagement with stakeholders help circumvent contextual and institutional barriers and creates incentives for sustained stakeholder interest in the engagement process [72].

4.4 Improved preparedness for future outbreaks

As a result of the co-production process, the DST developed allows for a greater degree of preparedness for future outbreaks, including identifying knowledge gaps. The integration of knowledge from different sectors allowed for the identification of priority data gaps that impact management, for example on geographical variation in public health coverage and therefore vaccination coverage.

In terms of future co-production of zoonotic disease tools and management, a key aspect to consider is the influence of power dynamics between sectors on the co-production process [13,67,72]. As Agyepong et al. [67] argues, unequal power relations can weaken co-production efforts and have negative ramifications, such as overlooking diverse forms of knowledge and perspectives. In addition, policy visibility of KFD changed over the process with events like large outbreaks in the Sagara district causing increasing interest and ownership from the public health sector at the expense of participation by the other sectors, whilst the outbreak of COVID-19 then redirected attention away from KFD. Whilst these externalities cannot necessarily be planned for, flexibility within the co-production process needs to be built in to allow for the ‘normal’ changes that are inherent to co-production processes (as was evident from the framing workshop), as well as the less common externalities. As part of the process, the project was able to adapt to input from stakeholders. A final consideration for future co-production processes is the need to manage expectations. As we noticed from the workshops, wider participation across sectors led to a larger “wish list” from a decision-support tool. This led to repeated attempts during and after workshops to manage expectations and time frames for the tool development. Such considerations need to be thought through and acted upon to avoid frustration from stakeholders and disengagement from the co-production process.

Outstanding questions, that are being addressed through a longer-term experimentation process, are whether the co-produced DSTs actually enhance disease preparedness in terms of human cases avoided due to improved targeting of interventions; whether the cross-sectoral engagement and ownership of the tool will be sustained; whether the tool can be fully embedded in health information systems and extended to other zoonotic diseases affecting forest communities. These notwithstanding, the foregoing has underscored the value of co-production approaches and how they could be highly applicable for operationalising OneHealth across different socio-spatial contexts.

Supporting information

S1 Fig. KFDExplorer Tool data flowchart showing the data flow processes to inform KFD surveillance and management.

(TIF)

S1 Table. The characteristics of the workshop participants.

(DOCX)

S2 Table. Prioritisation of KFD risk factors identified by stakeholders and what changed or was strengthened over the co-production workshops.

(DOCX)

S1 Text. Self-completion questionnaire for Workshop participants.

(DOCX)

Acknowledgments

We are extremely grateful to the stakeholders from across the Animal Health, Human Health, Forestry and Social Welfare sectors, community groups in India who gave up their valuable time to share their knowledge and experience with the project team. We appreciate the entire MonkeyFeverRisk project team. In particular, we acknowledge Drs F. Gerard, N. Balakrishnan and S. Bhat for their kind assistance with facilitation during the workshop and Dr G. Ainsworth for assistance with stakeholder mapping and workshop planning.

Data Availability

Given the potential of identifying the individual who participated in our multi-stakeholder workshops and violating their confidentiality, our study dataset will not be shared openly but may be available upon specific request. Researchers wishing to access the dataset used in this study should contact the UK Centre for Ecology & Hydrology Institutional Data Access contact via Jim Chiazzese (email: jimchi@ceh.ac.uk). The disease case data cannot be shared publicly due to Reasonable Security Practices and Procedures and Sensitive Personal Data or Information Rules enforced by Government of India. Researchers wishing to access the human outbreak data used in this study should contact the following officials at the Department of Health and Family Welfare Services, Government of Karnataka, Director (email: director-hfws@karnataka.gov.in), Joint Director of Communicable Diseases (CMD) (email: jdcmd-hfws@karnataka.gov.in).

Funding Statement

The MonkeyFeverRisk project that led to these results is supported by the Global Challenges Research Fund and funded by the MRC, AHRC, BBSRC, ESRC and NERC [grant numbers MR/P024335/1 and MR/P024335/2], awarded to BVP, SLH, MVM, ATV, MMC, MAO, JCY, PNS, SJB and GK. PNS received support from the DBT/Wellcome Trust India Alliance Fellowship number IA/CPHI.16/1/502648. Additional support was provided to BVP and FAA from the NERC SUNRISE project [grant number NE/R000131/1]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008. Feb;451(7181):990–3. doi: 10.1038/nature06536 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Grace D, Gilbert J, Randolph T, Kang’ethe E. The multiple burdens of zoonotic disease and an ecohealth approach to their assessment. Tropical animal health and production. 2012. Sep;44(1):67–73. https://link.springer.com/article/10.1007/s11250-012-0209-y. doi: 10.1007/s11250-012-0209-y [DOI] [PubMed] [Google Scholar]
  • 3.Halliday JE, Allan KJ, Ekwem D, Cleaveland S, Kazwala RR, Crump JA. Endemic zoonoses in the tropics: a public health problem hiding in plain sight. Veterinary Record. 2015. Feb; 176 (9):220–5. doi: 10.1136/vr.h798 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Halliday J, Daborn C, Auty H, Mtema Z, Lembo T, Bronsvoort BM, et al. Bringing together emerging and endemic zoonoses surveillance: shared challenges and a common solution. Philosophical Transactions of the Royal Society B: Biological Sciences. 2012. Oct 19; 367(1604):2872–80. doi: 10.1098/rstb.2011.0362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Guerra CA, Snow RW, Hay SI. A global assessment of closed forests, deforestation and malaria risk. Annals of tropical medicine and parasitology. 2006. Apr; 100(3):189. doi: 10.1179/136485906X91512 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Chaves LF, Cohen JM, Pascual M, Wilson ML. Social exclusion modifies climate and deforestation impacts on a vector-borne disease. PLOS Neglected tropical diseases. 2008. Feb 6; 2(2):e176. doi: 10.1371/journal.pntd.0000176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Walsh JF, Molyneux DH, Birley MH. Deforestation: effects on vector-borne disease. Parasitology. 1993. Jan; 106(S1):S55–75. doi: 10.1017/s0031182000086121 [DOI] [PubMed] [Google Scholar]
  • 8.Lambin EF, Tran A, Vanwambeke SO, Linard C, Soti V. Pathogenic landscapes: interactions between land, people, disease vectors, and their animal hosts. International journal of health geographics. 2010. Dec; 9(1):1–3. 10.1186/1476-072X-9-54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Murray KA, Daszak P. Human ecology in pathogenic landscapes: two hypotheses on how land use change drives viral emergence. Current opinion in virology. 2013. Feb 1; 3(1):79–83. doi: 10.1016/j.coviro.2013.01.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Plowright RK, Reaser JK, Locke H, Woodley SJ, Patz JA, Becker DJ, et al. Land use-induced spill-over: a call to action to safeguard environmental, animal, and human health. The Lancet Planetary Health. 2021. Mar 6. 10.1016/S2542-5196(21)00031-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Reaser JK, Witt A, Tabor GM, Hudson PJ, Plowright RK. Ecological countermeasures for preventing zoonotic disease outbreaks: when ecological restoration is a human health imperative. Restoration Ecology. 2021. Feb 18:e13357. doi: 10.1111/rec.13357 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Paul MM, Jadeja NB, Sidhu N, Vanak AT. Whither One Health in India?. National Institute of Advanced Studies, Bangalore. 2020. Dec 12; 55(49):40. [Google Scholar]
  • 13.Asaaga FA, Young JC, Oommen MA, Chandarana R, August J, Joshi J, et al. Operationalising the “One Health” approach in India: facilitators of and barriers to effective cross-sector convergence for zoonoses prevention and control. BMC public health. 2021. Dec;21(1):1–21. doi: 10.1186/s12889-020-10013-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.World Health Organisation (WHO). National focal points–International Heath Regulations Secretariat. 2021. Available from: https://www.who.int/teams/ihr/national-focal-points. [Google Scholar]
  • 15.Asokan GV, Asokan V. Bradford Hill’s criteria, emerging zoonoses, and One Health. Journal of epidemiology and global health. 2016. Sep 1; 6(3):125–9. doi: 10.1016/j.jegh.2015.10.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kelly TR, Karesh WB, Johnson CK, Gilardi KV, Anthony SJ, Goldstein T, et al. One Health proof of concept: Bringing a transdisciplinary approach to surveillance for zoonotic viruses at the human-wild animal interface. Preventive veterinary medicine. 2017. Feb 1; 137:112–8. doi: 10.1016/j.prevetmed.2016.11.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lebov J, Grieger K, Womack D, Zaccaro D, Whitehead N, Kowalcyk B, et al. A framework for One Health research. One Health. 2017. Jun 1;3:44–50. doi: 10.1016/j.onehlt.2017.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chatterjee P, Kakkar M, Chaturvedi S. Integrating one health in national health policies of developing countries: India’s lost opportunities. Infectious diseases of poverty. 2016. Dec; 5(1):1–5. doi: 10.1186/s40249-016-0181-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dzingirai V, Bett B, Bukachi S, Lawson E, Mangwanya L, Scoones I, et al. Zoonotic diseases: who gets sick, and why? Explorations from Africa. Critical Public Health. 2017. Jan 1; 27(1):97–110. 10.1080/09581596.2016.1187260. [DOI] [Google Scholar]
  • 20.Leach M, Scoones I. The social and political lives of zoonotic disease models: narratives, science and policy. Social science & medicine. 2013. Jul 1; 88:10–7. doi: 10.1016/j.socscimed.2013.03.017 [DOI] [PubMed] [Google Scholar]
  • 21.Wright S, Nelson N. Participatory research and participant observation: two incompatible approaches. Power and participatory development: Theory and practice. 1995:43–59. [Google Scholar]
  • 22.Durham Community Research Team . Community-based participatory research: Ethical challenges. Retrieved October. 2011. [Google Scholar]
  • 23.Nowotny H, Scott P, Gibbons M. Re-thinking science: Knowledge and the public in an age of uncertainty. Cambridge: Polity; 2001. Mar 30.Available from: http://www.scielo.org.ar/pdf/cts/v1n1/v1n01a14.pdf. [Google Scholar]
  • 24.Zinsstag J, Schelling E, Bonfoh B, Fooks AR, Kasymbekov J, Waltner-Toews D, et al. Towards a ‘One Health’ research and application tool box. Veterinaria italiana. 2009. Jan 1;45(1):121–33. [PubMed] [Google Scholar]
  • 25.Gibbons M, Limoges C, Nowotny H, Schwartzman S, Scott P, Trow M. The new production of knowledge: The dynamics of science and research in contemporary societies. Sage; 1994. Sep 9. [Google Scholar]
  • 26.Pearce J. ’We Make Progress Because We are Lost’: Critical Reflections on Co Producing Knowledge as a Methodology for Researching Non-governmental Public Action. 2008. [Google Scholar]
  • 27.Campbell HJ, Vanderhoven D. Knowledge that matters: realising the potential of co-production. 2016. Available from: https://eprints.whiterose.ac.uk/99657/1/Final%20Report%20-%20Co-Production%20-%20%202016-01-20.pdf. [Google Scholar]
  • 28.Ainsworth GB, Redpath SM, Wilson M, Wernham C, Young JC. Integrating scientific and local knowledge to address conservation conflicts: Towards a practical framework based on lessons learned from a Scottish case study. Environmental Science & Policy. 2020. May 1; 107:46–55. 10.1016/j.envsci.2020.02.017. [DOI] [Google Scholar]
  • 29.Redman S, Greenhalgh T, Adedokun L, Staniszewska S, Denegri S, Co-production of Knowledge Collection Steering Committee. Co-production of knowledge: the future. 2021; 372:n434. doi: 10.1136/bmj.n434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Aslin H, Brown V. Towards whole of community engagement: A practical toolkit. Murray-Darling Basin Commission. 2004. Available from: http://hdl.handle.net/1885/77450. [Google Scholar]
  • 31.Moller H, Berkes F, Lyver PO, Kislalioglu M. Combining science and traditional ecological knowledge: monitoring populations for co-management. Ecology and society. 2004. Dec 1; 9(3). https://www.jstor.org/stable/26267682. [Google Scholar]
  • 32.Prado HM, Murrieta RS, Adams C, Brondizio ES. Complementary viewpoints: scientific and local knowledge of ungulates in the Brazilian Atlantic Forest. Journal of Ethnobiology. 2013. Dec; 33(2):180–202. [Google Scholar]
  • 33.Burgess J, Clark J, Harrison CM. Knowledges in action: an actor network analysis of a wetland agri-environment scheme. Ecological economics. 2000. Oct 1;35(1):119–32. 10.1016/S0921-8009(00)00172-5. [DOI] [Google Scholar]
  • 34.McCool SF. Building consensus: legitimate hope or seductive paradox?. US Department of Agriculture, Forest Service, Rocky Mountain Research Station; 2000. [Google Scholar]
  • 35.Bardosh KL, Scoones JC, Grace D, Kalema-Zikusoka G, Jones KE, de Balogh K, et al. Engaging research with policy and action: what are the challenges of responding to zoonotic disease in Africa?. Philosophical Transactions of the Royal Society B: Biological Sciences. 2017. Jul 19; 372(1725):20160172. doi: 10.1098/rstb.2016.0172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Rüegg SR, McMahon BJ, Häsler B, Esposito R, Nielsen LR, Ifejika Speranza C, et al. A blueprint to evaluate One Health. Frontiers in public health. 2017. Feb 16; 5: 20. doi: 10.3389/fpubh.2017.00020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Belay ED, Kile JC, Hall AJ, Barton-Behravesh C, Parsons MB, Salyer S, et al. Zoonotic disease programs for enhancing global health security. Emerging infectious diseases. 2017. Dec;23(Suppl 1):S65. doi: 10.3201/eid2313.170544 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Grant C, Iacono GL, Dzingirai V, Bett B, Winnebah TR, Atkinson PM. Moving interdisciplinary science forward: integrating participatory modelling with mathematical modelling of zoonotic disease in Africa. Infectious Diseases of Poverty. 2016. Dec; 5(1):1–2. doi: 10.1186/s40249-016-0110-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Davidson-Hunt IJ, Michael O’Flaherty R. Researchers, indigenous peoples, and place-based learning communities. Society and natural resources. 2007. Feb 13;20(4):291–305. 10.1080/08941920601161312. [DOI] [Google Scholar]
  • 40.Davidson-Hunt I, Berkes F. Learning as you journey: Anishinaabe perception of social-ecological environments and adaptive learning. Conservation ecology. 2003. Dec 1;8(1). Available from https://www.jstor.org/stable/26271978. [Google Scholar]
  • 41.Berkes F. Community-based conservation in a globalized world. Proceedings of the National academy of sciences. 2007. Sep 25;104(39):15188–93. 10.1007/s11069-006-9036-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wolfson M, Wagoner KG, Rhodes SD, Egan KL, Sparks M, Ellerbee D, et al. Coproduction of research questions and research evidence in public health: the study to prevent teen drinking parties. BioMed research international. 2017. Jun 14;2017. 10.1155/2017/3639596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.De Rosis S, Pennucci F, Noto G, Nuti S. Healthy living and co-production: Evaluation of processes and outcomes of a health promotion initiative co-produced with adolescents. International Journal of Environmental Research and Public Health. 2020. Jan;17(21):8007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Elwyn G, Price A. Engaging patients in healthcare improvement and innovation. Improving Patient Care: The Implementation of Change in Health Care. 2020. Apr 15:253–62. 10.1002/9781119488620.ch14. [DOI] [Google Scholar]
  • 45.Barnett T, Pfeiffer DU, Hoque MA, Giasuddin M, Flora MS, Biswas PK, et al. Practising co-production and interdisciplinarity: Challenges and implications for one health research. Preventive veterinary medicine. 2020. Apr 1;177:104949. doi: 10.1016/j.prevetmed.2020.104949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Luchenski S., Edge C., Hutchinson-Pascal N., Sulta B., Black G., Burridge S., et al. Co-Production of Research and Advocacy Agenda for Inclusion Health. The Lancet 394 (S68). 10.1016/S0140-6736(19)32865-X. [DOI] [Google Scholar]
  • 47.Kasabi GS, Murhekar MV, Sandhya VK, Raghunandan R, Kiran SK, Channabasappa GH et al. Coverage and effectiveness of Kyasanur forest disease (KFD) vaccine in Karnataka, South India, 2005–10. PLoS neglected tropical diseases. 2013. Jan 24; 7(1):e2025. doi: 10.1371/journal.pntd.0002025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kiran SK, Pasi A, Kumar S, Kasabi GS, Gujjarappa P, Shrivastava A, et al. Kyasanur Forest disease outbreak and vaccination strategy, Shimoga District, India, 2013–2014. Emerging infectious diseases. 2015. Jan; 21(1):146. doi: 10.3201/eid2101.141227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ajesh K, Nagaraja BK, Sreejith K. Kyasanur forest disease virus breaking the endemic barrier: An investigation into ecological effects on disease emergence and future outlook. Zoonoses and public health. 2017. Nov; 64(7):e73–80. doi: 10.1111/zph.12349 [DOI] [PubMed] [Google Scholar]
  • 50.Oliveira A, Selvaraj K, Tripathy JP, Betodkar U, Cacodcar J, Wadkar A. Kyasanur Forest Disease vaccination coverage and its perceived barriers in Goa, India—A mixed methods operational research. Plos one. 2019. Dec 31; 14(12):e0226141. doi: 10.1371/journal.pone.0226141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Asaaga FA, Rahman M, Kalegowda SD, Mathapati J, Savanur I, Srinivas PN, et al. ‘None of my ancestors ever discussed this disease before!’ How disease information shapes adaptive capacity of marginalised rural populations in India. PLoS Neglected Tropical Diseases. 2021. Mar 11; 15(3):e0009265. doi: 10.1371/journal.pntd.0009265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Patil DY, Yadav PD, Shete AM, Nuchina J, Meti R, Bhattad D, et al. Occupational exposure of cashew nut workers to Kyasanur Forest disease in Goa, India. International Journal of Infectious Diseases. 2017. Aug 1; 61: 67–9. doi: 10.1016/j.ijid.2017.06.004 [DOI] [PubMed] [Google Scholar]
  • 53.Pattnaik P. Kyasanur forest disease: an epidemiological view in India . Reviews in medical virology. 2006. May;16(3):151–65. doi: 10.1002/rmv.495 [DOI] [PubMed] [Google Scholar]
  • 54.Murhekar MV, Kasabi GS, Mehendale SM, Mourya DT, Yadav PD, Tandale BV. On the transmission pattern of Kyasanur Forest disease (KFD) in India. Infectious diseases of poverty. 2015. Dec;4(1):1–4. doi: 10.1186/2049-9957-4-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Burthe SJ, Schäfer SM, Asaaga FA, Balakrishnan N, Chanda MM, Darshan N, et al. Reviewing the ecological evidence base for management of emerging tropical zoonoses: Kyasanur Forest Disease in India as a case study. PLoS neglected tropical diseases. 2021. Apr 1; 15(4):e0009243. doi: 10.1371/journal.pntd.0009243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Abbas SS. Working together for prevention and control of zoonoses in India (Doctoral dissertation, University of Sussex). Available from https://core.ac.uk/download/pdf/201000399.pdf.
  • 57.Yasobant S, Bruchhausen W, Saxena D, Falkenberg T. One health collaboration for a resilient health system in India: Learnings from global initiatives. One Health. 2019. Dec 1; 8:100096. doi: 10.1016/j.onehlt.2019.100096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Coker R, Rushton J, Mounier-Jack S, Karimuribo E, Lutumba P, Kambarage D, et al. Towards a conceptual framework to support one-health research for policy on emerging zoonoses. The Lancet infectious diseases. 2011. Apr 1; 11(4):326–31. doi: 10.1016/S1473-3099(10)70312-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Khayatzadeh-Mahani A, Wittevrongel K, Petermann L, Graham ID, Zwicker JD. Stakeholders’ engagement in co-producing policy-relevant knowledge to facilitate employment for persons with developmental disabilities. Health research policy and systems. 2020. Dec;18(1):1–7. doi: 10.1186/s12961-019-0494-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.McMillan SS, Kelly F, Sav A, Kendall E, King MA, Whitty JA, et al. Using the nominal group technique: how to analyse across multiple groups. Health Services and Outcomes Research Methodology. 2014. Sep;14(3):92–108. 10.1007/s10742-014-0121-1. [DOI] [Google Scholar]
  • 61.Purse BV, Darshan N, Kasabi GS, Gerard F, Samrat A, George C, et al. Predicting disease risk areas through co-production of spatial models: The example of Kyasanur Forest Disease in India’s forest landscapes. PLoS neglected tropical diseases. 2020. Apr 7;14(4):e0008179. doi: 10.1371/journal.pntd.0008179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in psychology. 2006. Jan 1;3(2):77–101. doi: 10.1191/1478088706qp063oa 32100154 [DOI] [Google Scholar]
  • 63.Hester PT, MacG K. Systemic decision making. Springer International Publishing AG; 2017. [Google Scholar]
  • 64.Marten R, El-Jardali F, Hafeez A, Hanefeld J, Leung GM, Ghaffar A. Co-producing the covid-19 response in Germany, Hong Kong, Lebanon, and Pakistan. bmj. 2021. Feb 16;372. 10.1136/bmj.n243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Farr M, Davies P, Andrews H, Bagnall D, Brangan E, Davies R. Co-producing knowledge in health and social care research: reflections on the challenges and ways to enable more equal relationships. Humanities and Social Sciences Communications. 2021. May 6;8(1):1–7. 10.1057/s41599-021-00782-1. [DOI] [Google Scholar]
  • 66.Steelman T, Nichols EG, James A, Bradford L, Ebersöhn L, Scherman V, et al. Practicing the science of sustainability: the challenges of transdisciplinarity in a developing world context. Sustainability Science. 2015. Oct;10(4):581–99. 10.1007/s11625-015-0334-4. [DOI] [Google Scholar]
  • 67.Agyepong IA, Godt S, Sombie I, Binka C, Okine V, Ingabire MG. Strengthening capacities and resource allocation for co-production of health research in low and middle income countries. BMJ. 2021. Feb 16;372. doi: 10.1136/bmj.n166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Hitziger M, Berezowski J, Dürr S, Falzon LC, Léchenne M, Lushasi K, et al. System thinking and citizen participation is still missing in One Health initiatives–Lessons from fifteen evaluations. Frontiers in public health. 2021;9. doi: 10.3389/fpubh.2021.653398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Marchino M, Paternoster G, Favretto AR, Balduzzi G, Berezowski J, Tomassone L. Process evaluation of integrated West Nile virus surveillance in northern Italy: an example of a One Health approach in public health policy. Evaluation and Program Planning. 2021. Aug 18:101991. doi: 10.1016/j.evalprogplan.2021.101991 [DOI] [PubMed] [Google Scholar]
  • 70.Lee K, Brumme ZL. Operationalizing the One Health approach: the global governance challenges. Health policy and planning. 2013. Oct 1;28(7):778–85. doi: 10.1093/heapol/czs127 [DOI] [PubMed] [Google Scholar]
  • 71.Galaz V, Leach M, Scoones I, Stein C. The political economy of One Health research and policy. Available from: https://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/6598. [Google Scholar]
  • 72.Tembo D, Hickey G, Montenegro C, Chandler D, Nelson E, Porter K, et al. Effective engagement and involvement with community stakeholders in the co-production of global health research. bmj. 2021. Feb 16;372. doi: 10.1136/bmj.n178 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Fawcett S, Schultz J, Watson-Thompson J, Fox M, Bremby R. Peer reviewed: Building multisectoral partnerships for population health and health equity. Preventing chronic disease. 2010. Nov;7(6). [PMC free article] [PubMed] [Google Scholar]
  • 74.Virani TE. Mechanisms of collaboration between creative small, medium and micro-sized enterprises and higher education institutions: reflections on the Creativeworks London Creative Voucher Scheme. Creativeworks London working papers. 2015. [Google Scholar]
  • 75.Aenishaenslin C, Hongoh V, Cissé HD, Hoen AG, Samoura K, Michel P, et al. Multi-criteria decision analysis as an innovative approach to managing zoonoses: results from a study on Lyme disease in Canada. BMC Public Health. 2013. Dec;13(1):1–6. 10.1186/1471-2458-13-897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Singer M, Bulled N. Ectoparasitic Syndemics: Polymicrobial Tick‐borne Disease Interactions in a Changing Anthropogenic Landscape. Medical anthropology quarterly. 2016. Dec; 30(4):442–61. doi: 10.1111/maq.12163 [DOI] [PubMed] [Google Scholar]
  • 77.Trowbridge P, Premkumar PS, Varghese GM. Prevalence and risk factors for scrub typhus in South India. Tropical Medicine & International Health. 2017. May;22(5):576–82. doi: 10.1111/tmi.12853 [DOI] [PubMed] [Google Scholar]
  • 78.Sehgal SC, Sugunan AP, Vijayachari P. Leptospirosis disease burden estimation and surveillance networking in India. Southeast Asian journal of tropical medicine and public health. 2003. Sep; 34:170–7. [PubMed] [Google Scholar]
  • 79.Kar NP, Kumar A, Singh OP, Carlton JM, Nanda N. A review of malaria transmission dynamics in forest ecosystems. Parasites & vectors. 2014. Dec;7(1):1–2. doi: 10.1186/1756-3305-7-265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Boden LA, McKendrick IJ. Model-based policymaking: A framework to promote ethical “good practice” in mathematical modelling for public health policymaking. Frontiers in public health. 2017. Apr 5; 5:68. doi: 10.3389/fpubh.2017.00068 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0000075.r001

Decision Letter 0

Giridhara Rathnaiah Babu, Julia Robinson

4 Sep 2021

PGPH-D-21-00480

Co-production of knowledge as part of a OneHealth approach to better control zoonotic diseases.

PLOS Global Public Health

Dear Dr. Asaaga,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 19 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Giridhara Rathnaiah Babu, MBBS, MBA, MPH (Epidemiology), PhD (Epidemiology)

Academic Editor

PLOS Global Public Health

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

At the outset, I take this opportunity to thank you personally, and all the reviewers recognize your hard work and motivation to charter in publishing the interdisciplinary work. Two of the reviewers have expressed that this manuscript merits an opportunity to publish provided the report of the results is modified and the manuscript is revised. One of the reviewers has pointed to self-citations and adapting another figure from your published manuscript. Please make the modifications as suggested by the reviewer.

At the conceptual level, we recognize that your team has profound knowledge of One Health. The rationale for the co-production process conducted against the established systems approach in One Health needs to be explained. I will be happy to receive a revised manuscript addressing the specific recommendations by the reviewers.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: N/A

Reviewer #3: No

Reviewer #4: N/A

Reviewer #5: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

Reviewer #5: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

Reviewer #5: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The co-production initiative that includes several stakeholders from public health, animal health and environment to create a DST would be very beneficial for the control of zoonotic diseases such as KFD. The information generated from the manuscript is highly relevant for future decision makers in One Heath. The authors did a great job in explaining the co-production process and how they could contribute to the future disease outbreak management.

However, the manuscript lack specific details on how the data were analyzed that resulted in the development of DST. Here are few suggestions for the authors

1. How were the stakeholders identified? Where they involved in policy/decision making process. It would be better to list out the title of the stake holders who attended both the workshops.

2. The authors should describe the approach used to develop desk-based spatial DST mentioned in line 219

3. The authors also need to give a detailed explanation on how the data generated from the two workshops were analyzed. For example how was the risk factors identified and how did they account of the unequal participation from different sectors (6 participants from public health vs 10 participants from animal health in Workshop 1)

4. What was the criteria used by the authors to either include or exclude the risk factors (line 278) and how was the users and uses identified by the stakeholders screened to select for the key potential users and uses (Table 3).

5. Is there any link for accessing the DST tool so that the reader could have a better understanding about the usefulness of the approach

Reviewer #2: It is a well written manuscript. There are a few punctuation errors that require attention. The introduction could be made more crisp and to the point.

In the manuscript as a whole, there are a few reiterations of things that have already been touched upon. The manuscript will benefit from an editing to make the entire thing seem more put-together and without any repetitions.

Kindly do the needful.

Reviewer #3: Title: If this co-production of knowledge is from a case study of southern India, then this should reflect on the title.

Abstract

L29: I could rather say, necessarily not working together. Although there might be some knowledge, and they may work under certain circumstances, this is not necessarily happening.

L32: reduction of disease impact or risk mitigation at the interface of human-animal-environment. The author may like to justify why they are saying the reduction of disease impact rather than risks.

L37: If the case study is about KFD, that must align with the L32 statement and reflect in the title.

Introduction

L55-56: It seems the sentence is not well placed.

L65-68: Difficult to generalize, as it strongly depends on the governance structure and the functionalities. Yes, it's true if it has been written from the Indian perspective, but authors need to specify here.

L74: Why ‘global’. One Health is local too. So why global One Health?

L77: The One Health sope is not just to reduce the disease impact. It must be valued as an integrated risk management perspective too.

L80-83: Which models authors are talking about? Need clarification

Overall well-written background; however, I have a gross critique. Why are authors introducing the concept of co-production here? In the rationale of the One Health approach, cross-sectoral collaboration is the base, and the theme lies with the systems approach. There must be a strong argument, how this co-production process is different from the systems approach of solving multi-dimensional issues, which is needed in the background.

Methods

L156-187: I could see multiple self-citations (please refer to other literature). Rather than writing about the whole disease management system here in the method section. It will be great to replace the KFD disease management system with a three-tier approach of central-state-local governance and all the stakeholders involved in this process.

Fig.1: It’s the same figure from author’s recently published article. Can I suggest developing a new framework specific to KFD, although the aim is to provide a generic system to readers?

L210-248: It is important how researchers invited these participants. In the participatory approach, it is an integral component as the outcome depends on who participated and the rank of the stakeholders, including experiences. Please explain and justify why there is a discrepancy in the number of stakeholders from three domains of One Health. Also, add a para on the pre-workshop-related development works.

Results

L271-284: Is there any decision-making tree analysis or hierarchical analysis conducted as part of the problem prioritization? If so, please specify. If not, then justify the process. And how the weightage calculation (if any) is conducted needs to be expanded. If not, then why there was no such process done, justify.

L303-341: Readers may like to have a brief idea of the KFD project outline prior to the workshop. And how that priority has changed over the co-production workshops.

L388-424: Some of the recommendations are aligned with the findings of this workshop. The authors may like to shift those recommendations (perhaps overall and specific) towards the end of the draft with a separate section.

Conclusion

Authors may like to provide a guidance framework in the form of process flow, including the impact matrix for better understanding. Also, link factors that could potentially affect each step of the process flow and minimize those.

Reviewer #4: This is an excellent article that makes a very timely contribution to our understanding of how to move the One Health approach from theory to practice. The structure of the paper is set out effectively and the overall argument supported well.

Suggestions for revisions:

In the methods section, there should be more information on how the data generated as part of the workshops was analyzed. Was it imported into Nvivo, or a similar qualitative research software? What type of analysis (thematic, constant comparative, discourse) was conducted? How were coding categories developed (inductively, deductively), etc?

It is interesting that stakeholders wanted to have the DST be integrated with WHO's IHIP but that this was not done. Could you provide more details on why.

Additional comments:

P.9 Fig.1 Capture should be shortened and acronyms placed at end of article.

P.22 line 329 Punctuation missing after the word direction

P.27 Fig.3 Capture should be shortened and figure explained in text/footnote not heading

Reviewer #5: General Comments:

The manuscript presents an interesting case study of a scientific project attempting to engage in a more inclusive process with stakeholders of their work. The reflective work done to prepare this manuscript is highly valuable and should be acknowledged. It is a known struggle for scientists accustomed to quantitative research to present qualitative work with the same rigor. The progress in inter- and transdisciplinary health sciences will require much more of these pioneering efforts. I therefore commend this work for publication after some thorough revision.

The article would benefit from some reorganisation according to the “standards for reporting qualitative research”. In particular, the result section should provide the data that the authors employ to draw their conclusions in the discussion section. As it stands, the article appears rather as an opinion piece than a scientific report from qualitative research. Also, the discussion should make substantially more reference to other work conducted in the field of one health and transdisciplinarity. Maybe, the authors could formulate a working hypothesis for the introduction of this work, which then would facilitate structuring the discussion.

Specific Comments:

L59: The link between ecosystem degradation and disease burden needs some broader references looking into the problem, e.g. highly relevant references would be

https://www.frontiersin.org/articles/10.3389/fvets.2021.661063/full ; https://doi.org/10.1016/j.biocon.2020.108707

L74-7: consider inverting the statement “...to endorse and facilitate health” instead of “…reduce the impact of diseases”. There are implications when focusing on diseases rather than health, particularly in regards to the stakeholders that are considered. When intending a one health approach, the objective should be positive rather than the absence of negative. For detailed rationale behind this, please see: https://link.springer.com/article/10.1007%2Fs11625-019-00674-z

L86-9: In the context of One Health, the authors could consider also referring to transdisciplinarity as a term used to describe knowledge co-production, e.g. http://www.ncbi.nlm.nih.gov/pubmed/20391395 ; http://link.springer.com/10.1007/s13280-012-0372-4 ; https://www.cabi.org/bookshop/book/9781789242577/

L102-4: Besides these pertinent aspects, the authors could consider mentioning that further aspects that require an integrated approach have been identified in the specific context of one health initiatives, namely improved equity, stewardship, and efficiency (https://www.frontiersin.org/articles/10.3389/fpubh.2017.00020/full)

L104-8: An important aspect that is missing here, is that citizens have tacit knowledge that must be mobilized for effective solutions. I.e. they have locally valid knowledge that is not scientifically recorded or available. In conventional approaches, such knowledge is often discovered throughout the project, but not included in the conception phase.

L 183: replace “actor” by “sector”.

L206: The inclusion/exclusion of stakeholders in a co-production process has fundamental impact on its outcomes. Hence it would be important here to outline the stakeholder management plan, including the identification, priorisation and engagement process.

L214: From the affiliation mentioned above, it seems that no citizen representatives were engaged. This may seriously hamper the resulting conclusions in regard to their applicability. This should be discussed in the limitations of this study.

L220: With “spillover”, usually events are described that are singular changes of host species, i.e. when SARS-CoV2 adapted from the intermediate host to humans, or NIPAH from pigs to humans. In the present case, the authors should refer to probability maps for human infections. A more detailed explanation of the differences can be found here: https://www.frontiersin.org/articles/10.3389/fpubh.2020.596944/full

L223: It might be of interest to the readers, how the authors handled intellectual property rights at this point. "Allowing" implies that this would have been prohibited otherwise.

L234: maybe state the objectives or provide a chart of the various steps in the co-production process with the corresponding stakeholders. E.g. it seems that the DST was developed in the lab by the authors, and then exposed to the assumed end-users for validation. It would be nice to see how the workshop1 information was integrated in the DST models.

L240: consider revising the verb “inputted”

L241: I suggest revising this sentence: "The workshop relied entirely on participation using a range of different methods including group discussions, brainstorming and priorization exercises."

The "approach" refers to the "attitude of the researchers" or "the more fundamental paradigm", while what they are describing are participatory methods. Whether these are engaging or not (qualification of the participation) essentially depends on the facilitators, thus the authors would have to declare the criteria for their self-assessment to declare if participation was high.

L244-6: What qualifies Fig 2 as a snapshot? As I understand, it is a graphical representation of the retrospective theory of change. Please omit “framework”. Please refine the process according to the comment above - or use a different figure.

L269: Consider using the heading "results". In my view, insights should be mentioned in the discussion section. In general please consider following the relevant guidelines from the equator network, e.g. the standards for reporting qualitative research:

https://www.equator-network.org/reporting-guidelines/srqr/

L280: It is interesting to read that the modelling approach (spatial risk models) seems to have been pre-defined by the authors. Implicitly this excludes much information that is eminently important for early warning, such as the monkey deaths. I would like to read some reflection on the choice of model and its impact on the ability to respond to the stakeholder expectations. Alternatives would have been e.g. Fuzzy cognitive maps or agent based modelling. For a more comprehensive list of possible participatory modelling approaches please refer to Voinov, 2018: https://doi.org/10.1016/j.envsoft.2018.08.028

L337: I assume, the authors mean "resolution" with “grain”.

L362: It is not quite clear to me, what ground-level means in this context and whether it is contrasted or synonym to the peripheral user, i.e. a field collaborator. Please specify the distinctions. It feels as if the authors were using a vertical and a concentric hierarchical image to express the same.

L370: This rationale ignores the real time information about monkey deaths, which is highly relevant. The implemented algorithm endorses a heuristic approach, which doesn't necessarily reflect the true probability of infection, i.e. it is excessively conservative and identifies high probabilities, where they may not occur anymore, while they'd ignore evidence for high probabilities, where no human cases have occurred.

Secondly the authors imply that the probability of infection equals the risk. However, in health sciences risk is usually the product of likelihood and consequences. In this case, the consequences would strongly depend on the subject being exposed to a certain likelihood. I suggest, the authors use “probability maps” or landscapes rather than "risk maps" as a term.

L388: The authors could reflect whether the users they identified are actually stakeholders or not potentially shareholders in the problem. The distinction has nicely been elaborated in "Systemic Decision Making" by Hester and Adams (2017, Springer). Usually, the agents responsible for the management are not suffering from the consequences of poor management and consequently are share- rather than stakeholders in regard to their motivation(s) to act. This is quite relevant when it comes to the stewardship generated by integrative projects. The issue was illustrated by an evaluation of previous one health projects including one from Kerala on KFD: https://www.frontiersin.org/articles/10.3389/fpubh.2021.653398/full

L401-4: This belongs in the methods

L442 ff: The authors don't seem to be aware of the various efforts that have previously been made to learn from one health initiatives and other transdisciplinary work. A starting point would be the Hitziger 2021 paper, but multiple others have been published and should be used to compare the conclusions drawn by the authors here.

In my view this discussion lacks references and reflection. While I acknowledge the self-comparison, I would highly recommend some external comparisons which would also allow to elaborate what was particularly exemplary in this project over other similar endeavors. e.g. http://journals.sagepub.com/doi/10.1177/160940690700600401; http://link.springer.com/10.1007/s11625-015-0334-4; http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-897; https://doi.org/10.1016/j.evalprogplan.2021.101991;

https://www.frontiersin.org/research-topics/5479/;

L466: Given the precedent project evaluated in Hitziger 2021, I don't think this claim “the first of its kind” is appropriate.

Figures:

Fig2:

Please also indicate how "culture of inter-sectorality, knowledge integration and preparedness were assessed (all other outcomes/ impacts have a criterion).

Fig3: please replace “spillover” by “human infections”

Tables:

Table 1 and 2: please replace “spillover” by “human infections”

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Fayiqa Ahamed Bahkir

Reviewer #3: Yes: Sandul Yasobant

Reviewer #4: No

Reviewer #5: Yes: Simon R. Rüegg

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0000075.r003

Decision Letter 1

Giridhara Rathnaiah Babu, Julia Robinson

9 Jan 2022

Co-production of knowledge as part of a OneHealth approach to better control zoonotic diseases.

PGPH-D-21-00480R1

Dear Dr. Asaaga,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at https://www.editorialmanager.com/pgph/ click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Kind regards,

Giridhara Rathnaiah Babu, MBBS, MPH, PhD

Academic Editor

PLOS Global Public Health

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #5: All comments have been addressed

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #5: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #5: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #5: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #5: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors did an excellent job in including relevant reviewer comments. Detailed description of methods utilized and data analysis and the limitations was very useful. Overall, the materials and methods reads well, however, introduction and discussion sections were pretty long and could be made more simple by avoiding redundancies.

Reviewer #2: The article is well-written, but there a few corrections to be made.

Introduction too long, please make it crisp and to the point.

Few spelling mistakes in the manuscript, kindly go through manually, as running an automated spell check might not pick up irrelevant words, examples as taken from the script below:

2.1.1 Actors involved in disease management in India

(line 214)exercise, which culminated in a list of current and potential cross-sectoral actors involved in

Reviewer #5: Congratulations to the authors. The discussion has greatly improved and exploited the potential of this work.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Fayiqa Ahamed Bahkir

Reviewer #5: Yes: Simon R. Rüegg, Section of Epidemiology, Vetsuisse Faculty, University of Zürich, Switzerland

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. KFDExplorer Tool data flowchart showing the data flow processes to inform KFD surveillance and management.

    (TIF)

    S1 Table. The characteristics of the workshop participants.

    (DOCX)

    S2 Table. Prioritisation of KFD risk factors identified by stakeholders and what changed or was strengthened over the co-production workshops.

    (DOCX)

    S1 Text. Self-completion questionnaire for Workshop participants.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers Comments_Final.docx

    Data Availability Statement

    Given the potential of identifying the individual who participated in our multi-stakeholder workshops and violating their confidentiality, our study dataset will not be shared openly but may be available upon specific request. Researchers wishing to access the dataset used in this study should contact the UK Centre for Ecology & Hydrology Institutional Data Access contact via Jim Chiazzese (email: jimchi@ceh.ac.uk). The disease case data cannot be shared publicly due to Reasonable Security Practices and Procedures and Sensitive Personal Data or Information Rules enforced by Government of India. Researchers wishing to access the human outbreak data used in this study should contact the following officials at the Department of Health and Family Welfare Services, Government of Karnataka, Director (email: director-hfws@karnataka.gov.in), Joint Director of Communicable Diseases (CMD) (email: jdcmd-hfws@karnataka.gov.in).


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES